Notably, altered RNR activity is associated with cancer and nucleobase analogs are frequently used as chemotherapeutics, commonly targeting RNR (Jordheim et al. 2013; Aye et al. 2015; Kohnken et al. 2015; Mathews 2015, 2018). Here, NR2E3 is linked to cancer.